Cleared Traditional

K032074 - LINICAL ESOTERICS CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER SYNCHRON ANALYZERS

K032074 is an FDA 510(k) clearance for LINICAL ESOTERICS CALIBRATION VERIFIERS..., manufactured by Cliniqa Corporation. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K032074 · Cliniqa Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
106d
Days
Class 1
Risk

K032074 is an FDA 510(k) clearance for the LINICAL ESOTERICS CALIBRATION VERIFIERS LEVELS A-E FOR BECKMAN COULTER SYNCHR.... Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Cliniqa Corporation (Fallbrook, US). The FDA issued a Cleared decision on October 21, 2003 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Cliniqa Corporation devices

FDA 510(k) Submission Details - K032074

510(k) Number K032074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2003
Decision Date October 21, 2003
Days to Decision 106 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 88d · This submission: 106d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 598
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K032074.
ELECSYS PRECICONTROL MULTIANALYTE
K033937 · Roche Diagnostics Corp. · Jan 2004
BAYER SPECIAL CHEMISTRY CONTROLS
K033379 · Bayer Diagnostics Corp. · Dec 2003
QUEST DIAGNOSTICS SERUM CHEMISTRY CONTROL, MODELS 935 AND 945
K033387 · Bio-Rad · Dec 2003
LINICAL CHEMISTRY CALIBRATION VERIFIERS LEVELS A-E FOR OLYMPUS AU SYSTEMS
K033162 · Cliniqa Corporation · Oct 2003
AUDIT MICROCONTROLS MICROFD BNP CONTROL
K032122 · Aalto Scientific, Ltd. · Sep 2003
N/T PROTEIN CONTROL
K032237 · Dade Behring, Inc. · Sep 2003